SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-15-028128
Filing Date
2015-05-07
Accepted
2015-05-07 06:00:49
Documents
2
Group Members
BAKER BROS. ADVISORS (GP) LLCFBB ASSOCIATESFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v409811_sc13da.htm SC 13D/A 115794
2 EXHIBIT 99.1 v409811_ex1.htm EX-99.1 79112
  Complete submission text file 0001144204-15-028128.txt   196712
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Subject) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52299 | Film No.: 15839224
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVE 21ST FLOOR NEW YORK NY 10065 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

IRS No.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A